Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • tlitman
    Junior Member
    • Jun 2008
    • 9

    #1

    Testing SOLiD vs Illumina

    We have tested SOLiD against Illumina for microRNA quantitation.
    Here is my conclusion:

    1. Both systems apparently measure the amount of miRNAs quantitatively
    2. The SOLiD system outputs 30M sequences per run (high density)
    3. The Illumina system outputs 6M sequences per run (standard density)
    4. The SOLiD system outputs a number of "isomiRs", which in our analysis are spurious reads due to "overfitting" to the reference genome
    5. The Illumina data are easier to analyse (no "color-space" issue)

    Recommendation:
    If ease of analysis is of importance, Illumina appears as the first choice.
    If sequence output is of importance, SOLiD has the lead.



    Thomas Litman
    Head of Biomarker Discovery
    Exiqon A/S
    Bygstubben 3
    DK-2950 Vedbaek
    DENMARK

    TEL +45 4565 0933
    MBL +45 4090 2135
    E-mail [email protected]
  • andibody
    Member
    • Mar 2008
    • 45

    #2
    Are you using a GAI or II?
    30M with the Solid? wow... I assume you can get this 8x per run?
    How long does it take to perform a run from RNA to aligned sequence with the Solid?

    Comment

    • tlitman
      Junior Member
      • Jun 2008
      • 9

      #3
      GAII and SOliD

      Illumina: GA II.

      SOLiD:
      The 30M are with high-density beads.
      We got 15M sequences with "normal" density beads.
      Yes, this was from a single "channel" run.
      The timing... hmm, it took several weeks before we got the data, but in principle, it should not take more than a week to run and analyze this "small" (2 samples) experiment.


      Originally posted by andibody View Post
      Are you using a GAI or II?
      30M with the Solid? wow... I assume you can get this 8x per run?
      How long does it take to perform a run from RNA to aligned sequence with the Solid?


      Thomas Litman
      Head of Biomarker Discovery
      Exiqon A/S
      Bygstubben 3
      DK-2950 Vedbaek
      DENMARK

      TEL +45 4565 0933
      MBL +45 4090 2135
      E-mail [email protected]

      Comment

      • Chipper
        Senior Member
        • Mar 2008
        • 323

        #4
        I would guess you got a quarter for the SOLiD (it does not hav channels or lanes but can be divided into quads or octet). Or you could use barcodes of course (currently 16 per spot).

        Run times are said to be 3.5 days with the 3.0 version (35 bases).

        Have you decided yet if and what to buy?

        Comment

        • tlitman
          Junior Member
          • Jun 2008
          • 9

          #5
          Correct, an octet, or rather: 2, one for each sample.

          Decisions: I am inclined towards the Illumina system, mainly because it is easier to analyze the data, and because the running cost is lower.
          both systems can do barcoding, although we did not barcode for this particular experiment (but for another run).


          Originally posted by Chipper View Post
          I would guess you got a quarter for the SOLiD (it does not hav channels or lanes but can be divided into quads or octet). Or you could use barcodes of course (currently 16 per spot).

          Run times are said to be 3.5 days with the 3.0 version (35 bases).

          Have you decided yet if and what to buy?


          Thomas Litman
          Head of Biomarker Discovery
          Exiqon A/S
          Bygstubben 3
          DK-2950 Vedbaek
          DENMARK

          TEL +45 4565 0933
          MBL +45 4090 2135
          E-mail [email protected]

          Comment

          • tlitman
            Junior Member
            • Jun 2008
            • 9

            #6
            running costs: please clarify

            Today (Thu, Nov 13 2008) I received a phone call from a person at Applied Biosystems (their sales director, Eric Norbart), who accused me for spreading inaccurate information in the public domain regarding the running cost of the SOLiD system compared to Illumina

            Therefore, before I retract my statement, I would like to ask both SOLiD and Illumina users to estimate their actual running cost of the systems. That is:
            Q: What is the cost per gigabase output of a 35 nt run per system?

            Thank you (for letting ABI know...)

            - Thomas

            Originally posted by tlitman View Post
            Correct, an octet, or rather: 2, one for each sample.

            Decisions: I am inclined towards the Illumina system, mainly because it is easier to analyze the data, and because the running cost is lower.
            both systems can do barcoding, although we did not barcode for this particular experiment (but for another run).


            Thomas Litman
            Head of Biomarker Discovery
            Exiqon A/S
            Bygstubben 3
            DK-2950 Vedbaek
            DENMARK

            TEL +45 4565 0933
            MBL +45 4090 2135
            E-mail [email protected]

            Comment

            • cgb
              Member
              • May 2008
              • 50

              #7
              comparison

              Don't be bullied - you are the customer ! Ive heard so much fooey over the years its a bit rich being accused of spreading false information by a vendor!

              1. there are no accurate costings out there - in fact there are a number of different ways of doing it. some people don't count capex at all.

              2. think 'run time', how much data per unit time do you get (that BTW - is the true definition of 'throughput') last time i looked a 'run' was not a standard fixed unit of time. so how much data can you make in 1 year or over the lifetime of the machine if run continuously?

              3. It is *very* hard to do like-for-like comparisons of colour-space data and illumina data. hence any accuracy claims should be viewed in context.

              4. cost per run is different question (i.e cost per gigabase). Does time to result cost anything ? or is it purely the costs of the reagents ?

              Comment

              • tlitman
                Junior Member
                • Jun 2008
                • 9

                #8
                Thanks for the reply, cgb

                We still have to decide on the HTS system.
                My impression is that ABI are under pressure, as they have been very aggressive in their attempt to convince us that their system is better and cheaper than Illumina's, while the latters sales reps seem much more relaxed - and thus, pleasant - in their presentations.

                Regarding time vs. cost:
                We are more concerned in the actual run cost than in run time, since I envisage the bottleneck will be in the downstream bioinformatics analysis rather than in throughput of sequence data


                Thomas Litman
                Head of Biomarker Discovery
                Exiqon A/S
                Bygstubben 3
                DK-2950 Vedbaek
                DENMARK

                TEL +45 4565 0933
                MBL +45 4090 2135
                E-mail [email protected]

                Comment

                • Chipper
                  Senior Member
                  • Mar 2008
                  • 323

                  #9
                  I think the barcoding will make SOLiD cometetive cost-wise since my understanding is that it has a higer sample prep cost but lower cost per Gb sequence.

                  Perhaps Eric could enlighten us on the actual reagent costs for a SOLiD run and library prep?

                  Comment

                  • csquared
                    Member
                    • May 2008
                    • 67

                    #10
                    Eric Norbart very likely did more harm than good with that phone call but that is pretty typical middle management for you.

                    You ABSOLUTLEY can run an Illumina instrument less expensive than the ABI when all factors are considered. How much less expensive will depend on lots of variables. However, if you consider the specs for the upcoming solid3 and its output, you can also argue that the 'per GB' cost on the solid3 will be less than the 'per GB' cost on the Illumina.
                    HudsonAlpha Institute for Biotechnology
                    http://www.hudsonalpha.org/gsl

                    Comment

                    • james hadfield
                      Moderator
                      Cambridge, UK
                      Community Forum
                      • Feb 2008
                      • 224

                      #11
                      They all cost an awful lot of money; to buy and to run. And if you are going to fork out around $500k for a machine you probably want to run it as much as possible which equals vast sums of money on kits and chemistry.
                      Of course much of this gets ignored as soon as you start to see the wonderful things we can do with these technologies and many people opt for a second machine quite quickly.

                      Comment

                      Latest Articles

                      Collapse

                      • SEQadmin2
                        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
                        by SEQadmin2



                        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

                        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
                        ...
                        10-14-2026, 09:55 AM
                      • SEQadmin2
                        New Genomics Technologies Take Aim at Long-Standing Limits
                        by SEQadmin2


                        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

                        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
                        ...
                        09-28-2026, 10:25 AM

                      ad_right_rmr

                      Collapse

                      News

                      Collapse

                      Topics Statistics Last Post
                      Started by SEQadmin2, 10-15-2026, 10:52 AM
                      0 responses
                      19 views
                      0 reactions
                      Last Post SEQadmin2  
                      Started by SEQadmin2, 10-14-2026, 05:39 AM
                      0 responses
                      26 views
                      0 reactions
                      Last Post SEQadmin2  
                      Started by SEQadmin2, 10-13-2026, 09:56 AM
                      0 responses
                      22 views
                      0 reactions
                      Last Post SEQadmin2  
                      Started by SEQadmin2, 10-09-2026, 11:14 AM
                      0 responses
                      28 views
                      0 reactions
                      Last Post SEQadmin2  
                      Working...